A Comparative Study of Selatogrel (ACT-246475) Formulations in Healthy Subjects
Part of paid clinical trials in Overland Park, Kansas.
- Sponsor
- Viatris Innovation GmbH
- Study ID
- NCT04557280
- Phase
- PHASE1
- Status
- Completed
Conditions
- Healthy Subjects
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 59 Years
- Healthy Volunteers
- Accepted
Interventions
- Selatogrel — COMBINATION_PRODUCTA single subcutaneous injection of 16 mg.
- Selatogrel — DRUGA single subcutaneous injection of 16 mg.
Study Details
The main purpose is to study the pharmacokinetics of selatogrel (ACT-246475) using different administration modes and formulations. The clinical pharmacology data will be used to support demonstration of bioequivalence and interchangeability of the different formulations.
Key Dates
- Start date
- Nov 6, 2020
- Status verified
- Nov 2022
- Primary completion
- Dec 19, 2020
- Completion
- Dec 19, 2020
Study Design
- Enrollment
- 24 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- OTHER
Arms
- Experimental: Treatment A: liquid formulation via auto-injectorSelatogrel will be administered as a liquid formulation in a sealed prefilled syringe in an auto-injector forming an integral ready-to-use single-dose drug delivery system.
- Experimental: Treatment B: liquid formulation via syringeSelatogrel will be administered as a liquid formulation in a sealed prefilled syringe.
- Experimental: Treatment C: lyophilizate-based formulation via syringeSelatogrel will be administered as a reconstituted lyophilizate-based formulation for injection.
Primary Outcome Measure
Area under the plasma concentration-time curve (AUC0-t) of selatogrel [ Time Frame: Multiple pharmacokinetic sampling at predefined times on Day 1 (pre-dose) up to Day 3. ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Altasciences Clinical Kansas, Inc | Overland Park | Kansas | 66212 | - |
Find similar trials in Overland Park, KS
By research site
Related Studies
- Oral Bacteria and Immune System Problems Involved in Gum Disease (Periodontitis)Recruiting · National Institute of Dental and Craniofacial Research (NIDCR) · Bethesda, Maryland
- Prospective Evaluation of Next Generation CT Reconstruction (NextGenIR)Recruiting · National Heart, Lung, and Blood Institute (NHLBI) · Bethesda, Maryland
- Optimizing Ultrasound-induced Anti-inflammation in Human SubjectsRecruiting · University of Virginia · Charlottesville, Virginia
- Single-tracer Multiparametric PET ImagingEARLY_PHASE1 · Recruiting · University of California, Davis · Sacramento, California